About Loncar Investments

About company

The Loncar Cancer Immunotherapy Index (LCINDX) seeks to track the performance of a transformational therapeutic field within the biotechnology space. Biotech stocks tend to get grouped together as a whole, yet areas like immunotherapy trade on their own unique circumstances and innovations. The goal of the Cancer Immunotherapy index is to give investors a better understanding of the immunotherapy sector by highlighting major companies involved and providing a metric to track their progress. They hope that highlighting immunotherapy in this fashion will lead to more awareness within the investment community, more investment in the field, and more progress for patients who battle cancer disease.